LONDON, UK: In 2018, GlaxoSmithKline (GSK), one of the world’s largest pharmaceutical companies, outlined its intention to separate its consumer healthcare portfolio into an independent entity. This is set to take place in mid-2022, and GSK has now revealed that the new company will be called Haleon.
The separation of GSK’s healthcare business, which is subject to approval from shareholders, will take place via a demerger of at least 80% of GSK’s stake in the business to shareholders later this year. According to a press release issued by GSK, Haleon’s name is derived from the words “hale”, an old English word meaning “in good health”, and “Leon”, a name associated with strength. Included in Haleon’s portfolio will be the paracetamol brand Panadol, the non-steroidal anti-inflammatory Voltaren and the toothpaste brand Sensodyne.
In January, GSK revealed that it had recently rejected three takeover offers for its consumer healthcare business from multinational conglomerate Unilever, including a bid of £50 billion (approximately US$67 billion). GSK said that Unilever had undervalued the business and forecast annual organic sales growth of 4 to 6%.
“Introducing Haleon to the world marks another step in our journey to become a new, standalone company,” said Haleon CEO designate Brian McNamara. “Our name is grounded in our purpose to deliver better everyday health with humanity and to be a world leader in consumer healthcare. We are on track to launch Haleon in mid-2022 and our business momentum is strong.”
Emma Walmsley, GSK CEO, added that “Haleon has enormous potential to improve health and well-being across the world with strong prospects for growth, and through listing will unlock significant value for GSK shareholders”.
Tags:
WASHINGTON, U.S.: Danaher, a global science and technology conglomerate operating in the field of healthcare, among others, has announced its intention to ...
is to save the tooth for use in the future. In this age of adhesive dentistry, respecting and preserving the remaining healthy tooth structure as well as ...
ROCHESTER, N.Y., USA: Carestream has announced that it will be selling its dental digital business to funds managed by Clayton, Dubilier & Rice, a global ...
CHANGZHOU, China: The Chinese dental supply company Eighteeth has acquired ZHEAN Healthcare, an innovative Chinese manufacturer specialising in the research...
ST. PAUL, Minn., US: 3M has announced that Solventum will be the name of the planned independent healthcare company that will be formed from a spin-off of ...
BASEL, Switzerland: The Straumann Group, a global leader in tooth replacement and orthodontic solutions, announced today that it has signed an agreement to ...
WASHINGTON, US: Danaher Corporation has announced that Envista Holdings Corporation will be the name of the separate company it is to take public via an ...
ALTSTÄTTEN, Switzerland: COLTENE has announced the appointment of Mattias Flodin as chief marketing officer, effective 1 November. Flodin, who brings ...
The demand for gorgeous, perfect smiles has exploded in recent years. During the COVID-19 pandemic, the amount of time spent behind the screen, whether in ...
BRISBANE, Australia: Artificial intelligence (AI) is emerging as a transformative force in Australian dentistry, and a new national review has mapped how ...
Live webinar
Mon. 15 September 2025
1:00 pm EST (New York)
Prof. Dr. med. dent. Stefan Wolfart
Live webinar
Tue. 16 September 2025
11:00 am EST (New York)
Prof. Dr. Dr. Florian Guy Draenert
Live webinar
Tue. 16 September 2025
12:30 pm EST (New York)
Dr. Kay Vietor, Birgit Sayn
Live webinar
Tue. 16 September 2025
1:00 pm EST (New York)
Dr. Paweł Aleksandrowicz PhD
Live webinar
Tue. 16 September 2025
8:00 pm EST (New York)
Live webinar
Wed. 17 September 2025
6:30 am EST (New York)
Live webinar
Wed. 17 September 2025
7:30 am EST (New York)
To post a reply please login or register